| Year |
Citation |
Score |
| 2024 |
Yoon S, Kim HY, Park S, Cha M, Kim K, Lee S, Kim J, Bhang S, Kim Y. Drug Discovery and Screening Tool Development for Tauopathies by Focusing on Pathogenic Tau Repeat 3 Oligomers. Angewandte Chemie (International Ed. in English). e202411942. PMID 39314129 DOI: 10.1002/anie.202411942 |
0.607 |
|
| 2024 |
Park S, Shin J, Kim K, Kim D, Lee WS, Lee J, Cho I, Park IW, Yoon S, Lee S, Kim HY, Lee JH, Hong KB, Kim Y. Modulation of Amyloid and Tau Aggregation to Alleviate Cognitive Impairment in a Transgenic Mouse Model of Alzheimer's Disease. Acs Pharmacology & Translational Science. 7: 2650-2661. PMID 39296253 DOI: 10.1021/acsptsci.4c00006 |
0.779 |
|
| 2022 |
Jung M, Lee S, Park S, Hong J, Kim C, Cho I, Sohn HS, Kim K, Park IW, Yoon S, Kwon S, Shin J, Lee D, Kang M, Go S, et al. A Therapeutic Nanovaccine that Generates Anti-amyloid Antibodies and Amyloid-specific Regulatory T cells for Alzheimer's Disease. Advanced Materials (Deerfield Beach, Fla.). e2207719. PMID 36329674 DOI: 10.1002/adma.202207719 |
0.685 |
|
| 2021 |
Park S, Kim Y. Bias-generating factors in biofluid amyloid-β measurements for Alzheimer's disease diagnosis. Biomedical Engineering Letters. 11: 287-295. PMID 34616582 DOI: 10.1007/s13534-021-00201-z |
0.673 |
|
| 2021 |
Park S, Kim HY, Oh HA, Shin J, Park IW, Yoon S, Woo DH, Kim Y. Quinacrine directly dissociates amyloid plaques in the brain of 5XFAD transgenic mouse model of Alzheimer's disease. Scientific Reports. 11: 12043. PMID 34103615 DOI: 10.1038/s41598-021-91563-y |
0.761 |
|
| Show low-probability matches. |